Am J Transplant, Volume 21, Suppl 3 Archives - Page 81 of 139 - ATC Abstracts

2021 American Transplant Congress
Implementation of the Kidney Team at Home Intervention: Evaluating Generalizability, Implementation Process, and Effects
S. Redeker¹, S. Ismail¹, R. Timman¹, J. van Busschbach¹, C. Boonstra², H. F. Brulez³, D. A. Hollander⁴, L. Hilbrands⁵, F. J. Bemelman⁶, S. P. Berger⁷, J. van der Wetering⁸, R. A. van den Dorpel⁹, M. A. Jansen-Dekker¹⁰, W. Weimar⁸, E. K. Massey⁸
¹Psychiatry, Erasmus MC, Rotterdam, Netherlands, ²De Viersprong, Rotterdam, Netherlands, ³Internal Medicine, OLVG, Amsterdam, Netherlands, ⁴Internal Medicine, JBZ, Den Bosch, Netherlands, ⁵Internal Medicine, Radboud UMC, Nijmegen, Netherlands, ⁶Internal Medicine, Amsterdam UMC, Amsterdam, Netherlands, ⁷Internal Medicine, UMCG, Groningen, Netherlands, ⁸Internal Medicine, Erasmus MC, Rotterdam, Netherlands, ⁹Internal Medicine, Maasstad Ziekenhuis, Rotterdam, Netherlands, ¹⁰Internal Medicine, ZGT, Almelo, Netherlands
*Purpose: Research has shown that a home-based educational intervention for patients with chronic kidney disease results in better knowledge and communication on all treatment options,…
2021 American Transplant Congress
Application of Incisional Wound Vac to Decrease Wound Complications and Surgical Site Infections: A Single Center Pilot Project
E. K. Venniro, M. Dokus, J. Taylor, R. Kashyap
University of Rochester Medical Center, Rochester, NY
*Purpose: Wound complications and surgical site infections (SSIs) are common but morbid complications of transplant in immunosuppressed patients. Kidney transplant patients who are obese, highly…
2021 American Transplant Congress
Longitudinal Studies of Blood Anellovirus DNA Prior to Acute Rejection or Major Infection Events in Pediatric Kidney Transplant Recipients (PKTx)
R. Dandamudi, H. Gu, C. Goss, H. Gula, K. Wylie, V. Dharnidharka
Washington University in St Louis, St. Louis, MO
*Purpose: Blood levels of the ubiquitous but non-pathogenic anellovirus (AnV) taxa have been postulated to represent a biomarker of the overall state of immunosuppression after…
2021 American Transplant Congress
Use of Donor-Derived Cell-Free DNA in Children with Kidney Transplantation: A Pilot Study
E. Winnicki, J. Brennan, M. McEnhill, P. Brakeman, E. Ku
UCSF, San Francisco, CA
*Purpose: Use of a blood test to detect donor-derived cell-free DNA (dd-cfDNA) levels has been shown to predict rejection in adults with kidney transplants. If…
2021 American Transplant Congress
Donor Derived Cell Free Dna: Teasing Out the Optimal Threshold for Antibody Mediated Rejection
M. Mattu¹, H. Murad¹, M. Merzkani¹, A. Malone¹, R. Delos Santos¹, M. Wang², B. Wang², S. Chang², T. Alhamad¹
¹Department of Medicine, Washington University in St Louis, St Louis, MO, ²Washington University in St Louis, St Louis, MO
*Purpose: Donor-derived cell-free DNA (dd-cfDNA) assay is a putative noninvasive marker for renal allograft rejection and other etiologies of injury such as BK nephropathy. The…
2021 American Transplant Congress
Belatacept Conversion in Proteinuric Renal Transplant Recipients: An Interventional Multi-Center Trial
O. Efe¹, A. Al Jurdi¹, D. Wojciechowski², K. Safa¹, H. Gilligan¹, A. Chandraker³, J. Azzi³, A. Weins³, L. V. Riella¹
¹Center for Transplantation Sciences, Massachusetts General Hospital, Charlestown, MA, ²UT Southwestern Medical Center, Dallas, TX, ³Brigham and Women’s Hospital, Boston, MA
*Purpose: Proteinuria develops in about 30% of kidney transplant recipients and is a strong predictor of graft loss. ACEis/ARBs can reduce proteinuria but are frequently…
2021 American Transplant Congress
The Importance of Persistent and Recurrent T Cell Mediated Rejection in Tacrolimus Treated Renal Transplant Recipients
C. Rampersad¹, I. W. Gibson², D. N. Rush¹, D. Pochinco³, P. E. Birk⁴, A. Goldberg⁴, T. Blydt-Hansen⁵, M. Karpinski¹, J. Shaw¹, J. Ho¹, P. W. Nickerson¹, C. Wiebe¹
¹Department of Medicine, University of Manitoba, Winnipeg, MB, Canada, ²Department of Pathology, University of Manitoba, Winnipeg, MB, Canada, ³Shared Health Services Manitoba, Winnipeg, MB, Canada, ⁴Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada, ⁵Department of Pediatrics, University of British Columbia, Winnipeg, MB, Canada
*Purpose: Optimal follow-up after treatment for T-cell mediated rejection (TCMR) is not well-established. We sought to identify the prevalence and clinical associations of repeated TCMR…
2021 American Transplant Congress
A Significantly Shorter Waiting Time to Subsequent Kidney Transplant After Liver Transplant by Using Safety Net Policy
P. Homkrailas, S. Bunnapradist
Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA
*Purpose: In August 2017, a new simultaneous liver-kidney transplant (SLK) allocation policy and medical eligibility criteria were introduced. These criteria aim to avoid dual organ…
2021 American Transplant Congress
Dynamics of IgG Subclass as a Mechanism of Desensitization Using Rituximab for Presensitized Patients Undergoing Living Related Liver Transplantation
H. Egawa¹, K. Ide², T. Ishizuka³, H. Ohdan⁴, Y. Kotera¹, T. Kato¹, A. Ohmori¹, Y. Hirata¹, G. Shibuya¹, S. Yamashita¹, S. Ariizumi¹
¹Tokyo Women's Medical University, Tokyo, Japan, ²Surgery, Hiroshima University, Hiroshima, Japan, ³Clinical Laboratory, Tokyo Women's Medical University, Tokyo, Japan, ⁴Hiroshima University, Hiroshima, Japan
*Purpose: Although impact of preformed HLA-related donor specific antibody (DSA) and necessity of desensitization in liver transplantation (LT) has been recognized, mechanisms of desensitization in…
2021 American Transplant Congress
Pilot Evaluation of Prognosis After Liver Transplantation in Patients with a History of Hepatocellular Carcinoma and Pd-1 Inhibition
M. Chen¹, Z. Chen¹, X. Lin²
¹First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ²the Eastern Hospital of the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
*Purpose: The successful applications of programmed death protein-1 (PD-1) inhibitors in cancer therapy has led to an expanding use of immunotherapy in oncolog Liver transplantation…